| Title | Author(s) | Issue date | ???itemlist.??? |
| Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database | Sokka, T.; Kautiainen, H.; Pincus, T.; Toloza, S.; da Rocha Castelar Pinheiro, G.; Lazovskis, J.; Hetland, M. L.; Peets, T.; Immonen, K.; Maillefert, J. F.; Drosos, A. A.; Alten, R.; Pohl, C.; Rojkovich, B.; Bresnihan, B.; Minnock, P.; Cazzato, M.; Bombardieri, S.; Rexhepi, S.; Rexhepi, M.; Andersone, D.; Stropuviene, S.; Huisman, M.; Sierakowski, S.; Karateev, D.; Skakic, V.; Naranjo, A.; Baecklund, E.; Henrohn, D.; Gogus, F.; Badsha, H.; Mofti, A.; Taylor, P.; McClinton, C.; Yazici, Y. | 24-Nov-2015 | - |
| EULAR points to consider for conducting clinical trials in systemic lupus erythematosus | Gordon, C.; Bertsias, G.; Ioannidis, J. P.; Boletis, J.; Bombardieri, S.; Cervera, R.; Dostal, C.; Font, J.; Gilboe, I. M.; Houssiau, F.; Huizinga, T. W.; Isenberg, D.; Kallenberg, C. G.; Khamashta, M. A.; Piette, J. C.; Schneider, M.; Smolen, J. S.; Sturfelt, G.; Tincani, A.; Van Vollenhoven, R.; Boumpas, D. T. | 24-Nov-2015 | - |
| EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints | Bertsias, G. K.; Ioannidis, J. P.; Boletis, J.; Bombardieri, S.; Cervera, R.; Dostal, C.; Font, J.; Gilboe, I. M.; Houssiau, F.; Huizinga, T.; Isenberg, D.; Kallenberg, C. G.; Khamashta, M.; Piette, J. C.; Schneider, M.; Smolen, J.; Sturfelt, G.; Tincani, A.; van Vollenhoven, R.; Boumpas, D. T.; Gordon, C. | 24-Nov-2015 | - |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs | Bertsias, G. K.; Ioannidis, J. P.; Aringer, M.; Bollen, E.; Bombardieri, S.; Bruce, I. N.; Cervera, R.; Dalakas, M.; Doria, A.; Hanly, J. G.; Huizinga, T. W.; Isenberg, D.; Kallenberg, C.; Piette, J. C.; Schneider, M.; Scolding, N.; Smolen, J.; Stara, A.; Tassiulas, I.; Tektonidou, M.; Tincani, A.; van Buchem, M. A.; van Vollenhoven, R.; Ward, M.; Gordon, C.; Boumpas, D. T. | 24-Nov-2015 | - |
| EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics | Bertsias, G.; Ioannidis, J. P.; Boletis, J.; Bombardieri, S.; Cervera, R.; Dostal, C.; Font, J.; Gilboe, I. M.; Houssiau, F.; Huizinga, T.; Isenberg, D.; Kallenberg, C. G.; Khamashta, M.; Piette, J. C.; Schneider, M.; Smolen, J.; Sturfelt, G.; Tincani, A.; van Vollenhoven, R.; Gordon, C.; Boumpas, D. T. | 24-Nov-2015 | - |
| European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres | Della Rossa, A.; Valentini, G.; Bombardieri, S.; Bencivelli, W.; Silman, A. J.; D'Angelo, S.; Cerinic, M. M.; Belch, J. F.; Black, C. M.; Becvar, R.; Bruhlman, P.; Cozzi, F.; Czirjak, L.; Drosos, A. A.; Dziankowska, B.; Ferri, C.; Gabrielli, A.; Giacomelli, R.; Hayem, G.; Inanc, M.; McHugh, N. J.; Nielsen, H.; Scorza, R.; Tirri, E.; van den Hoogen, F. H.; Vlachoyiannopoulos, P. G. | 24-Nov-2015 | - |
| European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes | Valentini, G.; Della Rossa, A.; Bombardieri, S.; Bencivelli, W.; Silman, A. J.; D'Angelo, S.; Cerinic, M. M.; Belch, J. F.; Black, C. M.; Bruhlman, P.; Czirjak, L.; De Luca, A.; Drosos, A. A.; Ferri, C.; Gabrielli, A.; Giacomelli, R.; Hayem, G.; Inanc, M.; McHugh, N. J.; Nielsen, H.; Rosada, M.; Scorza, R.; Stork, J.; Sysa, A.; van den Hoogen, F. H.; Vlachoyiannopoulos, P. J. | 24-Nov-2015 | - |
